Regulation of amyloid precursor protein cleavage

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 443-460

  Mills, Julia ^a   Reiner, Peter B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Amyloid; Alzheimer's disease; Amyloid precursor protein; Second messengers

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CHOLESTEROL; CYTOKINE; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; PROTEIN KINASE C;

ALZHEIMER DISEASE; ENZYME ACTIVATION; HUMAN; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; SHORT SURVEY; SIGNAL TRANSDUCTION; STRESS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; HUMANS; SECOND MESSENGER SYSTEMS;

EID: 0032960305     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720443.x     Document Type: Short Survey

References (240)

1. Ancolio K., Murambaud P., Dauch P., and Checler F. (1997) α-Secretase-derived product of β-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J. Neurochem. 69, 2494-2499.
2. Anderson J. P., Esch F. S., Keim P. S., Sambamurti K., Lieberburg I., and Robakis N. K. (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci. Lett. 128, 126-128.
3. Anderson J. P., Chen Y., Kim K. S., and Robakis N. K. (1992) An alternative secretase cleavage produces soluble Alzheimer amyloid precursor protein containing a potentially amyloidogenic sequence. J. Neurochem. 59, 2328-2331.
4. Barelli H., Lebeau A., Vizzuvona J., Delaere P., Chevallier N., Drouot C., Marambaud P., Ancolio K., Buxbaum J. D., Khorkova O., Heroux J., Sahasrabudhe S., Martinez J., Warter J. M., Mohr M., and Checler F. (1997) Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 3, 695-707.
5. Barger S. W. and Mattson M. P. (1996) Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol. Brain Res. 40, 116-126.
6. Barger S. W., Fiscus R. R., Ruth P., Hofmann F., and Mattson M. P. (1995) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J. Neurochem. 64, 2087-2096.
7. Baskin F., Rosenberg R. N., and Greenberg B. D. (1991) Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells. J. Neurosci. Res. 29, 127-132.
8. Benussi L., Govoni S., Gasparini L., Binetti G., Trabucchi M., Bianchetti A., and Racchi M. (1998) Specific role for protein kinase Cα in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts. Neurosci. Lett. 240, 97-101.
9. Bodovitz S. and Klein W. L. (1996) Cholestrol modulates α-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436-4440.
10. Borchelt D. R., Thinakaren G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T., Prada C.-M., Kim G., Seekins S., Yager D., Slunt H. H., Wang R., Seeger M., Levey A. I., Gandy S. E., Copeland N. G., Jenkins N. A., Price D. L., Younkin S. G., and Sisodia S. S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
11. Bowes M., Masliah E., Otero D., Zivin J., and Saitoh T. (1994) Reduction of neurological damage by a peptide segment of the amyloid β-A4 protein precursor in rabbit spinal cord ischemic model. Exp. Neurol. 129, 112-119.
12. Brousseau T., Legrain S., Berr C., Gourlet V., Vidal O., and Amouyel P. (1994) Confirmation of the ∈4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 44, 342-344.
13. Brown M. S. and Goldstein J. L. (1986) A receptor-mediated pathway lor cholesterol homeostasis. Science 232, 34-47.
14. Brown M. S. and Goldstein J. L. (1997) The SREP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331-340.
15. Busciglio J., Gabuzda D. H., Matsudaira P., and Yanker B. A. (1993) Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA 90, 2092-2096.
16. Buxbaum J. D. and Greengard P. (1996) Regulation of APP processing by intra- and intercellular signals. Ann. NY Acad. Sci. 777, 327-331.
17. Buxbaum J. D., Gandy S. E., Cicchetti P., Ehrlich M. E., Czernik A. J., Fracasso R. P., Ramabhadran T. V., Unterbeck A. J., and Greengard P. (1990) Processing of Alzheimer β/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. USA 87, 6003-6006.
18. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S. E., and Greengard P. (1992) Cholinergic agonists and interleukin 1 regulate processing and release of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89, 10075-10078.
19. Buxbaum J. D., Koo E. H., and Greengard P. (1993) Protein phosphorylation inhibits production of Alzheimer amyloid β/A4 peptide. Proc. Natl. Acad Sci. USA 90, 9195-9198.
20. Buxbaum J. D., Ruefli A. A., Parker C. A., Cypess A. A., and Greengard P. (1994) Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. USA 91, 4489-4493.
21. Cai X.-D., Golde T. E., and Younkin G. S. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-516.
22. Caporaso G. L., Gandy S. E., Buxbaum J. D., Ramabhadran T. V., and Greengard P. (1992) Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 3055-3059.
23. Caputi A., Barindelli S., Pastorino L., Cimino M., Buxbaum J. D., Cattabeni F., and Di Luca M. (1997) Increased secretion of the amino-terminal fragment of amyloid precursor protein in brains of rats with a constitutive up-regulation of protein kinase C. J. Neurochem. 68, 2523-2529.
24. Checler F. (1995) Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65, 1431-1444.
25. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D. J. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-amyloid production. Nature 360, 672-674.
26. Citron M., Teplow D. B., and Selkoe D. J. (1995) Generation of amyloid β protein from its precursor is sequence specific. Neuron 14, 661-670.
27. Citron M., Diehl T. S., Gordon G., Biere A. L., Seubert P., and Selkoe D. J. (1996) Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA 93, 13170-13175.
28. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George-Hyslop P., and Selkoe D. J. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72.
29. Clarris H. J., Nurcombe V., Small D. H., Beyreuther K., and Masters C. L. (1994) Secretion of nerve growth factor from septum stimulates neurite outgrowth and release of the amyloid protein precursor of Alzheimer's disease from hippocampal explants. J. Neurosci. 38, 248-258.
30. Cook D. G., Sung J. C., Golde T. E., Felsenstein K. M., Wojcyk B. S., Tanzi R. E., Trojanowski J. Q., Lee V. M., and Doms R. W. (1996) Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA 93, 9223-9228.
31. Cook D. G., Forman M. S., Sung J. C., Leight S., Kolson D. L., Iwatsubo T., Lee V. M.-L., and Doms R. W. (1997) Alzheimer's A β (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3, 1021-1023.
32. Cordell B. (1994) β-Amyloid formation as a potential therapeutic target for Alzheimer's disease. Annu. Rev. Pharmacol. Toxicol. 34, 69-89.
33. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., and Pericak-Vance M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
34. Criado M., Eibl H., and Barrantes F. J. (1982) Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry 21, 3622-3629.
35. da Cruz e Silva O. A. B., Iverfeldt K., Oltersdorf T., Sinha S., Lieberburg I., Ramabhadran T. V., Suzuki T., Sisodia S. S., Gandy S., and Greengard P. (1993) Regulated cleavage of Alzheimer β-amyloid precursor protein in the absence of the cytoplasmic tail. Neuroscience 57, 873-877.
36. Davis-Salinas J., Saporito-Irwin S. M., Donovan F. M., Cunningham D. D., and Van Nostrand W. E. N. (1994) Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid β-protein precursor. J. Biol. Chem. 269, 22623-22627.
37. Dekosky S. T. and Scheff S. W. (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlations with cognitive severity. Ann. Neurol. 27, 457-464.
38. Desdouits-Magnen J., Desdouits F., Takeda S., Syu L.-J., Saltiel A. R., Buxbaum J. D., Czernik A. J., Nairn A. C., and Greengard P. (1998) Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J. Neurochem. 70, 524-530.
39. De Strooper B., Umans L., Van Leuven F., and Van der Berghe H. (1993) Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway. J. Cell Biol. 121, 295-304.
40. De Strooper B., Simons M., Multhaup G., Leuven F. V., Beyreuther K., and Dotti C. G. (1995) Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J. 14, 4932-4938.
41. Dyrks T., Monning U., Beyreuther K., and Turner J. (1994) Amyloid precursor protein secretion and βA4 amyloid generation are not mutually exclusive. FEBS Lett. 349, 210-214.
42. Efthimiopoulos S., Felsenstein K. M., Sambamurti K., Robakis N. K., and Refolo L. M. (1994) Study of the phorbol ester effect on Alzheimer amyloid precursor processing: sequence requirements and involvement of cholera toxin sensitive protein. J. Neurosci. Res. 38, 81-90.
43. Efthimiopoulos S., Punji S., Manolopoulos V., Pangalos M., Wang G. P., Refolo L. M., and Robakis N. K. (1996) Intracellular cyclic AMP inhibits constitutive and phorbol ester-stimulated secretory cleavage of amyloid precursor protein. J. Neurochem. 67, 872-875.
44. 2 activation influences the processing and secretion of the amyloid precursor protein. Biochem. Biophys. Res. Commun. 197, 292-297.
45. Ensinger H. A., Doods H. N., Immel-Sehr A. R., Kuhn F. J., Lambrecht G., Mendia K. D., Muller R. E., Mutschler E., Sagrada A., Walther G., and Hammer R. (1993) WAL 2014 - a muscarinic agonist with preferential neuron-stimulating properties. Life Sci. 2, 473-480.
46. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., and Ward P. J. (1990) Cleavage of β-amyloid peptide during constitutive processing of its precursor. Science 248, 1122-1124.
47. Estus S., Golde T. E., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X. M., Tabira T., Greenberg B. D., and Younkin S. G. (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255, 726-728.
48. Farber S. A., Nitsch R. M., Schulz J. G., and Wurtman R. J. (1995) Regulated secretion of β-amyloid precursor protein in rat brain. J. Neurosci. 15, 7442-7451.
49. 2 and its role in brain tissue. J. Neurochem. 69, 889-901.
50. 2 in neurodegeneration. Neurochem. Int. 0, 517-522.
51. Fraser S. P., Suh Y.-H., and Djamgoz M. B. A. (1997) Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments. Trends Neurosci. 20, 67-72.
52. Fukuyama R., Chandrasekaran K., and Rapoport S. I. (1993) Nerve growth factor-induced neuronal differentiation is accompanied by differential induction and localization of the amyloid precursor protein (APP) in PC12 cells and variant PC12S cells. Mol. Brain Res. 17, 17-22.
53. Fuller S. J., Storey E., Li Q.-X., Smith A. I., Beyreuther K., and Masters C. L. (1995) Intracellular production of β3A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochemistry 34, 8091-8098.
54. Furukawa K. and Mattson M. P. (1998) Secreted amyloid precursor protein a selectively suppresses N-methyl-D-aspanate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience 83, 429-438.
55. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379, 74-78.
56. Furukawa K., Sopher B., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., Fox M., and Mattson M. P. (1996b) Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein is conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882-1896.
57. Gabuzda D., Busciglio J., and Yanker B. A. (1993) Inhibition of β-amyloid production by activation of protein kinase C. J. Neurochem. 61, 2326-2329.
58. Gabuzda D., Busciglio J., Chen L. B., Matsudaira P., and Yanker B. A. (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269, 13623-13628.
59. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seuhert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-525.
60. Gasparini L., Racchi M., Benussi L., Curti D., Binetti G., Bianchetti A., Trabucchi M., and Govoni S. (1997) Effect of energy storage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci. Lett. 231, 113-117.
61. Giacobini E. (1996) New trends in cholinergic therapy for Alzheimer's disease: nicotinic agonists or cholinesterase inhibitors. Prog. Brain Res. 109, 311-323.
62. Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., and Hardy J. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
63. Goedert M. (1987) Neuronal localization of amyloid β protein precursor mRNA in normal human brain and in Alzheimer's disease. EMBO J. 6, 3627-3632.
64. Gong C.-X., Singh T. J., Grundke-Iqbal I., and Iqbal K. (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61, 921-927.
65. Gowing E., Roher A. E., Woods A. S., Cotter R. J., Chaney M., Little S. P., and Ball M. J. (1994) Chemical characterization of Aβ17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J. Biol. Chem. 269, 10987-10990.
66. Gray C. W. and Patel A. J. (1993) Induction of β-amyloid precursor protein isoform mRNAs by bFGF in astrocytes. Neuroreport 4, 811-814.
67. Greenberg S. M., Koo E. H., Selkoe D. J., Qiu W. Q., and Kosik K. S. (1994) Secreted β-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances T phosphorylation. Proc. Natl. Acad. Sci. USA 91, 7104-7108.
68. Greenberg S. M., Qiu W. Q., Selkoe D. J., Ben-Itzhak A., and Kosik K. S. (1995) Amino-terminal region of the β-amyloid precursor protein activates mitogen-activated protein kinase. Neurosci. Lett. 198, 52-56.
69. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C, Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., and Selkoe D. J. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
70. Haass C. Hung A. Y., Schlossmacher M. G., Teplow D. B., and Selkoe D. J. (1993) β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021-3024.
71. Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159.
72. Hartmann T., Bieger S. C. Bruhl B., Tienari P. J., Ida N., Allsop D., Roberts G. W., Masters C. L., Dotti C. G., Unsicker K., and Beyreuther K. (1997) Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nat. Med. 3, 1016-1020.
73. Higaki J., Quon D., Zhong A., and Cordell B. (1995) Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular sites of catabolism. Neuron 14, 651-659.
74. Hock C., Golombowski S., Mullerspahn F., Naser W., Beyreuther K., Monning U., Schenk D., Vigopelfrey C., Bush A. M., Moir T., Tanzi R. E., Growdon J. H., and Nitsch R. M. (1998) Cerebro-spinal fluid levels of amyloid precursor protein and amyloid β-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity. Eur. Neurol. 39, 111-118.
75. Hogan M. V., Pawlowska Z., Yang H.-A., Kornecki E., and Ehrlich Y. H. (1995) Surface phosphorylation by ecto-protein kinase C in brain neurons: a target for Alzheimer's β-amyloid peptides. J. Neurochem. 65, 2022-2030.
76. 1-42 suppresses acetylcholine synthesis. J. Biol. Chem. 272, 2038-2041.
77. Howland D. S., Trusko S. P., Savage M. J., Reaume A. G., Lang D. M., Hirsch J. D., Maeda N., Siman R., Greenberg B. D., Scott R. W., and Flood D. G. (1998) Modulation of secreted β-amyloid precursor protein and amyloid β-peptide in brain by cholesterol. J. Biol. Chem. 273, 16576-16582.
78. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. (1996) Correlative memory deficits. Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-103.
79. Huber G., Martin J. R., Loffler J., and Moreau J. L. (1993) Involvement of amyloid precursor protein in memory formation in the rat: an indirect antibody approach. Brain Res. 603, 348-352.
80. Hung A. Y. and Selkoe D. J. (1994) Selective ectodomain phosphorylation and regulated cleavage of β-amyloid precursor protein. EMBO J. 13, 534-542.
81. Hung A. Y., Haass C. Nitsch R. M., Qiu W. Q., Citron M., Wurtman R. J., Growdon J. H., and Selkoe D. J. (1993) Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J. Biol. Chem. 268, 22959-22962.
82. Igbavboa U., Avdulov N. A., Chochina S. V., and Wood W. G. (1997) Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E. or both proteins. J. Neurochem. 69, 1661-1667.
83. Ikezu T., Trapp B. D., Song K. S., Schlegel A., Lisanti M. P., and Okamoto T. (1998) Caveolae, plasma membrane microdomains for α-secretase-mediated processing of the amyloid precursor protein. J. Biol. Chem. 273, 10485-10495.
84. Ishiguro M., Ohsawa I., Takamura C., Morimoto T., and Kohsaka S. (1998) Secreted form of β-amyloid precursor protein activates protein kinase C and phospholipase C-γ-1 in cultured embryonic rat neocortical cells. Mol. Brain Res. 53, 24-32.
85. Jacobsen J. S., Spruyt M. A., Brown A. M., Sahasrabubhe S. R., Blume A. J., Vitek M. P., Muenkel H. A., and Sonnenberg-Reines J. (1994) The release of Alzheimer's disease β-amyloid peptide is reduced by phorbol treatment. J. Biol. Chem. 269, 8376-8382.
86. Jaffe A. B., Toran-Allerand C. D., Greengard P., and Gandy S. E. (1994) Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J. Biol. Chem. 269, 13065-13068.
87. Jin L. W., and Saitoh T. (1995) Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy Drugs Aging 6, 136-149.
88. Jolly-Tornetta C., Gao Z., Lee V. M.-Y., and Wolf B. A. (1998) Regulation of amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons (NT2N). J. Biol. Chem. 273, 14015-14021.
89. Kaltschmidt B., Uherek M., Volk B., and Baeuerle P. A. (1997) Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 2642-2647.
90. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Master C. L., Grzeschik K. H., Multhaup G., Beyreuther K., and Muller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325, 733-736.
91. Kar S., Seto D., Gaudreau P., and Quirion R. (1996) β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J. Neurosci. 16, 1034-1040.
92. Kelly J. F., Furukawa K., Barger S. W., Rengen M. R., Mark R. J., Blanc E. M., Roth G. S., and Mattson M. P. (1996) Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA 93, 6753-6758.
93. Kim S.-H., Kim Y.-K., Jeong S.-J., Haass C. Kim Y.-H., and Suh Y.-H. (1997) Enhanced release of secreted form of Alzheimer's amyloid precursor protein from PC12 cells by nicotine. Mol. Pharmacol. 52, 430-436.
94. Kinouchi T., Ono Y., Sormachi H., Ishiura S., and Suzuki K. (1995a) Arachidonate metabolites affect the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein. Biochem. Biophys. Res. Commun. 209, 841-849.
95. Kinouchi T., Sorimachi H., Maruyama K., Mizuno K., Ohno S., Ishiura S., and Suzuki K. (1995b) Conventional protein kinase C (PKC)-α and novel PKC∈ but not -δ. increase the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein from PKC cDNA transfected 3Y1 fibroblasts. FEBS Lett. 364, 203-206.
96. Kirazov L., Loffler T., Schliebs R., and Bigl V. (1997) Glutamate-stimulated secretion of amyloid precursor protein from cortical rat brain slices. Neurochem. Int. 30, 557-563.
97. Klafki H. W., Abramowski D., Swoboda R., Paganetti P. A., and Staufenbiel M. (1996) The carboxyl termini of β-amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities. J. Biol. Chem. 271, 28655-28659.
98. 2+ increase in rat cultured hippocampal neurones. Br. J. Pharmacol. 123, 1483-1489.
99. Koliatsos V. E. (1996) Biological therapies for Alzheimer's disease: focus on trophic factors. Crit. Rev: Neurobiol. 10, 205-238.
100. Kornhauser J. M. and Greenberg M. E. (1997) A kinase to remember: dual roles for MAP kinase in long-term memory. Neuron 18, 839-842.
101. Kosik K. S. (1993) Alzheimer's disease: a cell biological perspective. Science 256, 780-783.
102. Kovacs D. M., Fausett H. J., Page K. J., Kim T.-W., Moir R. D., Merriam D. E., Hollister R. D., Hallmark O. G., Mancini R., Felsenstein K. M., Hyman B. T., Tanzi R. E., and Wasco W. (1996) Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2, 224-229.
103. Kuentzel S. L., Ali S. M., Altman R. A., Greenberg B. D., and Raub T. J. (1993) The Alzheimer β-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem. J. 295, 367-378.
104. Kuo Y.-M., Emmerling M. R., Vigo-Pelfrey C. Kasunic T. C., Kirkpatrick J. B., Murdoch G. H., Ball M. J., and Roher A. E. (1996) Water-soluble Aβ (N40, N42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077-4081.
105. Lahiri D. K. and Nall C. (1995) Promoter activity of the gene encoding the β-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid, and interleukin-1. Mol. Brain Res. 32, 233-240.
106. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448-6453.
107. LeBlanc A. C. (1995) Increased production of 4 kDa amyloid β peptide in serum deprived human primary neurons cultures: possible involvement of apoptosis. J. Neurosci. 15, 7837-7846.
108. LeBlanc A. C., Chen H., Autilio-Gambetti L., and Gambetti P. (1991) Differential APP gene expression in neonatal rat cerebral cortex, meninges and primary astroglial, neuronal and microglial cell. FEBS Lett. 292, 171-178.
109. LeBlanc A. C., Koutroumanis M., and Goodyer C. G. (1998) Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Aβ production in human primary neuron cultures. J. Neurosci. 15, 2907-2913.
110. Lee R. K. K. and Wurtman R. J. (1997) Metabotropic glutamate receptors increase amyloid precursor protein processing in astrocytes: inhibition by cyclic AMP. J. Neurochem. 68, 1830-1835.
111. Lee R. K. K., Wurtman R. J., Cox A. J., and Nitsch R. M. (1995) Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. USA 92, 8083-8087.
112. Lehtonen J. Y. A., Holopainen J. M., and Kinnunen P. K. J. (1996) Activation of phospholipase A, by amyloid β-peptides in vitro. Biochemistry 35, 9407-9414.
113. Lemere C. A., Lopera F., Kosik K. S., Lendon C. L., Ossa J., Saido T. C., Yamaguchi H., Ruiz A., Martinez A., Madrigal L., Hincapie L., Carlos Arango L. J., Anthony D. C., Koo E. H., Goate A. M., Selkoe D. J., and Carlos Arango V. J. (1996) The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2, 1146-1150.
114. Levitzki A. and Gazit A. (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782-1788.
115. Li J., Xu M., Zhou H., Ma J., and Potter H. (1997) Alzheimer presenilins in the nuclear membrane interphase kinetochores and centrosomes suggest a role in chromosome segregation. Cell 90, 917-927.
116. Lisanti M. P., Scherer P. E . Vidugiriene J., Tang Z.-L., Hermanoski-Vosatka A., Tu Y.-H., Cook R. F., and Sargiacomo M. (1994) J. Cell. Biol. 126, 111-126.
117. Luo Y., Hirashima N., Li Y., Alkon D., Sunderland T., Etcheberrigaray R., and Wolozin B. (1995) Physiological levels of β-amyloid increase tyrosine phosphorylation and cytosolic calcium. Brain Res. 681, 65-74.
118. Luo Y., Sunderland T., and Wolozin B. (1996) Physiological levels of β-amyloid activate phosphatidylinositol 3-kinase with the involvement of tyrosine phosphorylation. J. Neurochem. 67, 978-987.
119. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
120. Marambaud P., Wilk S., and Checler F. (1996) Protein kinase A phosphorylation of the proteasome: a contribution to the α-secretase pathway in human cells. J. Neurochem. 67, 2616-2619.
121. Marambaud P., Chevallier N., Barelli H., Wilk S., and Checler F. (1997a) Proteasome contributes to the α-secretase pathway of amyloid precursor protein in human cells. J. Neurochem. 68, 698-703.
122. Marambaud P., Lopez-Perez E., Wilk S., and Checler F. (1997b) Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's β-amyloid precursor protein: different control of early and late events by the proteasome. J. Neurochem. 69, 2500-2505.
123. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., and Games D. (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16, 5795-5811.
124. Masters C., Simms G., Weinman N., Multhaup G., McDonald B., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
125. Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25, 439-450.
126. Mattson M. P. (1997) Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081-1132.
127. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I., and Rydel R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10, 243-254.
128. Mattson M. P., Barger S. W., Furukawa K., Bruce A. J., Wyss-Coray T., Mark R. J., and Mucke L. (1997) Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease. Brain Res. Rev. 23, 47-61.
129. McGeer P. L. and McGeer E. G. (1996) Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann. NY Acad. Sci. 777, 213-220.
130. Mills J. and Reiner P. B. (1996) Phorbol esters but not the cholinergic agonist oxotremorine-M and carbachol increase release of the amyloid precursor protein in cultured rat cortical neurons. J. Neurosci. 67, 1511-1518.
131. Mills J., Charest D. L., Lam F., Beyreuther K., Ida N., Pelech S. L., and Reiner P. B. (1997) Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 17, 9415-9422.
132. Mitchell D. C., Straume M., Miller J. L., and Litman B. J. (1990) Modulation of metarhodopson formation by cholesterol-induced ordering of bilayer lipids. Biochemistry 29, 9143-9149.
133. Mobley W. C., Neve R. L., Prusiner S. B., and McKinley M. P. (1988) Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid protein precursor in developing hamster brain. Proc. Natl. Acad. Sci. USA 85, 9811-9815.
134. Moechars D., Lorent K., De Strooper B., Dewachter I., and Van Leuven F. (1996) Expression in brain of amyloid precursor protein mutated in the α-secretase site causes disturbed behaviour, neuronal degeneration and premature death in transgenic mice. EMBO J. 15, 1265-1274.
135. Mohr E., Mendis T., Rusk I. N., and Grimes J. D. (1994) Neurotransmitter replacement therapy in Alzheimer's disease. j. Psychiatr. Neurosci. 19, 17-23.
136. Moir R. D., Lynch T., Bush A. I., Whyte S., Henry A., Portbury S., Multhaup G., Small D. H., Tanzi R. E., Beyreuther K., and Masters C. L. (1998) Relative increase in Alzheimer's disease of soluble forms of cerebral Aβ amyloid protein precursor containing the Kunitz protease inhibitory domain. J. Biol. Chem. 273, 5013-5019.
137. s in rat brain cortex. Neuroreport 6, 633-636.
138. Morrison J. H. and Hof P. R. (1997) Life and death of neurons in the aging brain. Science 278, 412-419.
139. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., and Lannfelt L. (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet. 1, 345-347.
140. 1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain. Life Sci. 60, 985-991.
141. Müller U., Cristina N., Li Z.-W., Wolfer D. P., Lipp H.-P., Rülicke T., Brandner S., Aguzzi A., and Weissmann C. (1994) Behavioural and anatomical deficits in mice homozygous for a modified β-amyloid precursor protein gene. Cell 79, 755-765.
142. Münch G., Thome J., Foley P., Schinzel R., and Riederer P. (1997) Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res. Rev. 23, 134-143.
143. Nalbantoglu J., Tirado-Santiago G., Lahsaïni A., Poirier J., Goncalves O., Verge G., Momoli F., Welner S. A., Massicotte G., Julien J.-P., and Shapiro M. L. (1997) Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500-505.
144. Naslund J., Schiernhorn A., Hellmann U., Lannfelt L., Roses A. D., Tuernberg L. O., Silberring J., Gandy S. E., Winblad B., Greengard P., Nordstedt D., and Terenius L. (1994) Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer's disease and normal aging. Proc. Natl. Acad. Sci. USA 91, 8378-8382.
145. Newton A. C. (1995) Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270, 28495-28498.
146. Nitsch R. M. and Growdon J. H. (1994) Role of neurotransmission in the regulation of amyloid β-protein precursor processing. Biochem. Pharmacol. 47, 1275-1284.
147. Nitsch R. M., Slack B. E., Wurtman R. J., and Growdon J. H. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of
148. Nitsch R. M., Farber S. A., Growdon J. H., and Wurtman R. J. (1993) Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. USA 90, 5191-5193.
149. Nitsch R. M., Slack B. E., Farber S. A., Borghesani P. R., Schulz J. G., Kim C., Felder C. C., Growdon J. H., and Wurtman R. J. (1994) Receptor-coupled amyloid precursor protein processing. Ann. NY Acad Sci. 881, 122-127.
150. Nitsch R. M., Deng M., Growdon J. H., and Wurtman R. J. (1996) Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J. Biol. Chem. 271, 4188-4194.
151. Nitsch R. M., Deng A., Wurtman R. J., and Growdon J. H. (1997) Metabotropic glutamate receptor subtype mGluR1α stimulates the secretion of the amyloid βprotein precursor ectodomain. J. Neurochem. 69, 704-712.
152. Nitsch R. M., Kim C., and Growdon J. H. (1998) Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease. Neurochem. Res. 23, 807-814.
153. O'Banion M. K. and Finch C. E. (1996) Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease. Neurobiol. Aging 17, 669-671.
154. Oltersdorf T., Ward P. J., Henriksson R., Beattie E. C., Neve R., Lieberburg I., and Frizt L. C. (1990) The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J. Biol. Chem. 265, 4492-4497.
155. Paganetti P. A., Lis M., Klafki H.-W., and Staufenbiel M. (1996) Amyloid precursor protein truncated at any of the α-secretase sites is not cleaved to β-amyloid. J. Neurosci. Res. 46, 283-293.
156. Palmert M. R., Podlisny B. M., Witker D. S., Oltersdorf T., Younkin L. H., Selkoe D. J., and Younkin S. G. (1989) The β-amyloid protein precursor of Alzheimer's disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc. Natl. Acad Sci. USA 86, 6338-6342.
157. Pasternack J. M., Palmert M. R., Usiak M., Wang R., Zurcher-Neely H., Gonzalez-De Whitt P. A., Fairbanks M. B., Cheung T., Blades D., Heinrikson R. L., Greenberg B. D., Cotter R. J., and Younkin S. G. (1992) Alzheimer's disease and control brain contain soluble derivatives of the amyloid protein precursor that end within the β amyloid protein region. Biochemistry 31, 10936-10940.
158. Pedersen W. A., Kloczewiak M. A., and Blusztajn J. K. (1996) Amyloid β-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. USA 93, 8068-8071.
159. Pelech S. L. and Charest D. L. (1996) Cell cycle control in progress, in Cell Cycle Research (Meijer L., Guidet S., Lim H. Y., and Tung H. Y. L., eds), pp. 33-52. Plenum Press, New York.
160. Peraus G. C., Masters C. L., and Beyreuther K. (1997) Late compartments of amyloid precursor protein transport in SY5Y cells are involved in β-amyloid secretion. J. Neurosci. 17, 7714-7724.
161. Petryniak M. A., Wurtman R. J., and Slack B. E. (1996) Elevated intracellular calcium concentration increases secretory processing of the amyloid precursor protein by a tyrosine phosphorylation-dependent mechanism. Biochem. J. 320, 957-963.
162. Pike C. J., Overman M. J., and Cotman C. W. (1995) Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro. J. Biol. Chem. 270, 23895-23898.
163. Poirier J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17, 525-530.
164. Poirier J., Minnich A., and Davignon J. (1995) Apolipoprotein E. synaptic plasticity and Alzheimer's disease. Ann. Med. 27, 663-670.
165. Querfurth H. W. and Selkoe D. J. (1994) Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 33, 4550-4561.
166. Querfurth H. W., Jiang J., Geiger J. D., and Selkoe D. J. (1997) Caffeine stimulates amyloid β-peptide release from β-amyloid precursor protein-transfected HEK293 cells. J. Neurochem. 69, 1580-1591.
167. Racchi M., Baetta R., Salvietti N., Ianna P., Franceschini G., Paoletti R., Fumagalli R., Govoni S., Trabucchi M., and Soma M. (1997) Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem. J. 322, 893-898.
168. Racchi M., Ianna P., Binetti G., Trabucchi M., and Govoni S. (1998) Bradykinin-induced amyloid precursor protein secretion: a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer's disease. Biochem. J. 330, 1271-1275.
169. Rawson R. B., Zelenski N. G., Nijhawan D., Ye J., Sakai J., Hasan M. T., Chang T. Y., Brown M. S., and Goldstein J. L. (1997) Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol. Cell 1, 47-57.
170. Rebeck G. W., Reiter J. S., Strickland D. K., and Hyman B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
171. Refolo L. M., Salton S. R., Anderson J. P., Mehta P., and Robakis N. K. (1989) Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC12 cell cultures. Biochem. Biophys. Res. Commun. 164, 664-670.
172. Ringheim G. E., Aschmies S., and Petko W. (1997) Additive effects of basic fibroblast growth factor and phorbol ester on β-amyloid precursor protein expression and secretion. Neurochem. Int. 30, 475-481.
173. Roch J. M., Masliah E., Roch-Levecq A. C., Sundsmo M. P., Otero D. A., Veinbergs I., and Saitoh T. (1994) Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc. Natl. Acad. Sci. USA 91, 7450-7454.
174. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
175. Roher A. E., Chaney M. O., Kuo Y.-M., Webster S. D., Stine W. B., Haverkamp L. J., Woods A. S., Cotter R. J., Tuohy J. M., Krafft G. A., Bonnell B. S., and Emmerling M. R. (1996) Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271, 20631-20635.
176. Roses A. D. (1996) The Alzheimer diseases. Curr. Opin. Neurobiol. 6, 644-650.
177. Rossner S., Ueberham U., Yu J., Kirazov L., Schliebs R., Perezpolo J. R., and Bigl V. (1997) In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity. Eur. J. Neurosci. 9, 2125-2134.
178. Sambamurti K., Shioi J., Anderson J. P., Papolla M. A., and Robakis N. (1992) Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells. J. Neurosci. Res. 33, 319-329.
179. Savage M. J., Trusko S. P., Howland D. S., Pinsker L. R., Mistretta S., Reaume A. G., Greenberg B. D., Siman R., and Scott R. W. (1998) Turnover of amyloid β-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18, 1743-1752.
180. Schorderet M. (1995) Alzheimer's disease: fundamental and therapeutics. Experientia 51, 99-105.
181. Schubert D., Jin L.-W., Saitoh T., and Cole G. (1989a) The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion. Neuron 3, 689-694.
182. Schubert D., La Carbiere M., Saitoh T., and Cole G. (1989b) Characterization of an amyloid β precursor protein that binds heparin and contains tyrosine sulfate. Proc. Natl. Acad. Sci. USA 86, 2066-2069.
183. Schwartz J. H. (1993) Cognitive kinases. Proc. Natl. Acad. Sci. USA 90, 8310-8313.
184. Seeger M., Nordstedt C., Petanceska S., Kovacs D. M., Gouras G. K., Hahne S., Fraser P., Levesque L., Czernik A. J., St. George-Hyslop P., Sisodia S. S., Thinakaran G., Tanzi R. E., Greengard P., and Gandy S. (1997) Evidence for phosphorylation and oligomeric assembly of presenilin I. Proc. Natl. Acad. Sci. USA 94, 5090-5094.
185. Selkoe D. J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
186. Selkoe D. J. (1993) Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16, 403-409.
187. Selkoe D. J. (1994) Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease. Curr. Opin. Neurobiol. 4, 708-716.
188. Selkoe D. J. (1997) Alzheimer's disease: genotypes, phenotypes and treatments. Science 275, 630-631.
189. Selkoe D. J., Podlisny M. B., Joachin C. A., Vickers E. A., Lee G., Fritz L. C., and Oltersdorf T. (1988) β-amyloid precursor protein of Alzheimer's disease occurs as 110-to 135-kilodalton membrane-associated proteins in neural and nonneuronal tissues. Proc. Natl. Acad. Sci. USA 85, 7341-7345.
190. Selkoe D. J., Yamazaki M., Citron M., Podlisny M. B., Koo E. H., Teplow D. B., and Haass C. (1996) The role of APP processing and trafficking pathways in the formation of amyloid β-protein. Ann. NY Acad. Sci. 777, 57-64.
191. Seubert P., Vigo-Pelfrey C. Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., and Schenk D. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327.
192. Seubert P., Oltersdorf T., Lee M. G., Barbour R., Blomquist C., Davis D. L., Bryant K., Fritz, L. C., Galasko D., Thal L. J., Lieberburg I., and Schenk D. B. (1993) Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361, 260-263.
193. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A. C., Montesi M. P., Sorbi S., Rainera I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R. J., Wasco W., Da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1995) Cloning of a gene hearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
194. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer M., Cai X. D., McKay D. M., Tintner R., Frangione B., and Younkin S. G. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129.
195. Simons M., De Strooper B. D., Multhaup G., Tienari P. J., Dotti C. G., and Beyreuther K. (1996) Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J. Neurosci. 16, 899-908.
196. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C. G., and Simons K. (1998) Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA 95, 6460-6464.
197. Sisodia S. S. (1992) β-Amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. USA 89, 6075-6079.
198. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., and Price D. L. (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248, 492-495.
199. Slack B. E., Nitsch R. M., Livneh E., Kunz G. M., Breu J., Eldar H., and Wurtman R. J. (1993) Regulation by phorbol esters of amyloid precursor protein release from Swiss 3T3 fibroblasts overexpressing protein kinase Cα. J. Biol. Chem. 268, 21097-21101.
200. Slack B. E., Breu J., Petryniak M. A., Srivastava K., and Wurtman R. J. (1995) Tyrosine phosphorylation of amyloid precursor protein secretion by the M3 muscarinic acetylcholine receptor. J. Biol. Chem. 270, 8337-8344.
201. Slack B. E., Breu J., Muchnicki L., and Wurtman R. J. (1997) Rapid stimulation of amyloid precursor protein release by epidermal growth factor: role of PKC. Biochem. J. 327, 245-246.
202. Smith-Swintosky V. L., Pettigrew L. C., Craddock S. D., Culwell A. R., Rydel R. E., and Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63, 781-784.
203. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L.-M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., and Roses A. D. (1993a) Binding of human apolipoprotein E to synthetic amyloid β-peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102.
204. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., and Roses A. D. (1993b) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
205. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K. H., Mistl C., Rothacher S., Ledermann B., Bürki K., Frey P., Paganetti P. A., Waridel C., Calhoun M. E., Jucker M., Probst A., Staufenbiel M., and Sommer B. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13287-13292.
206. Suzuki T., Nairn A. C., Gandy S. E., and Greengard P. (1992) Phosphorylation of Alzheimer amyloid precursor protein by protein kinase C. Neuroscience 48, 755-761.
207. Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A., St. George-Hyslop P., Van Keuren M. L., Patterson D., Pagan S., Kurnit D. M., and Neve R. L. (1987) Amyloid β protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 235, 880-884.
208. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., and Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairments. Ann. Neurol. 30, 572-580.
209. Thastrup O., Cullen P., Drobak B., Hanley M., and Dawdson A. (1990) Thapsigargin, a tumor promoter, discharges intracellular calcium stores by a specific inhibition of the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 87, 2466-2470.
210. Thinakaran G., Borchelt D. R., Lee M. K., Slum H. H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A. I., Gandy S. E., Jenkins N. A., Copeland N. G., Price D. L., and Sisodia S. S. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190.
211. Tienari P. J., Ida N., Ikonen E., Simons M., Weidemann A., Multhaup G., Masters C. L., Dotti C. G., and Beyreuther K. (1997) Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 94, 4125-4130.
212. Tischer E. and Cordell B. (1996) β-Amyloid precursor protein: location of transmembrane domain and specificity of γ-secretase cleavage. J. Biol. Chem. 271, 21914-21919.
213. Tomita S., Kirino Y., and Suzuki T. (1998) Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. J. Biol. Chem. 273, 6277-6284.
214. Toran-Allerand C. D. (1996) The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev. Neurosci. 18, 36-48.
215. Tsai M.-J. and O'Malley B. W. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
216. 42 are generated intracellularly in cultured neurons and their secretion increases with maturation. J. Biol. Chem. 271, 8966-8970.
217. Ullrich A. and Schlessinger J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
218. Ulus I. H. and Wurtman R. J. (1997) Metabotropic glutamate receptor agonists increase release of soluble amyloid precursor protein derivatives from rat brain cortical and hippocampal slices. J. Pharmacol. Exp. Ther. 281, 149-154.
219. Vasilakos J. P., Carroll R. T., Emmerling M. R., Doyle P. D., Davis R. E., Kim K. S., and Shivers B. D. (1994) Interleukin-1β dissociates β-amyloid precursor protein and β-amyloid peptide secretion. FEBS Lett. 354, 289-292.
220. Vonkoch C. S., Zheng H., Chen H., Trumbauer M., Thinakaran G., Vanderploeg L. H. T., Price D. L., and Sisodia S. S. (1997) Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging 18, 661-669.
221. Wallace W. C., Lieberburg I., Schenk D., Vigo-Pelfrey C., Davis K. L., and Haroutunian V. (1995) Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats. J. Neurosci. 15, 4896-4905.
222. Walter J., Grunberg J., Capell A., Pesold B., Schindzielorz A., Citron M., Mendla K., St. George-Hyslop P., Multhaup G., Selkoe D. J., and Haass C. (1997) Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C. Proc. Natl. Acad. Sci. USA 94, 5349-5354.
223. Wang R., Meschia J. F., Cotter R. J., and Sisodia S. S. (1991) Release of the β/A4 amyloid precursor protein: identification of a cleavage site in cultured mammalian cells. J. Biol. Chem. 266, 16960-16964.
224. Weidemann A., Konig G., Bunke D., Fischer P., Salbaum J. M., Master C. L., and Beyreuther K. (1989) Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115-126.
225. Weidemann A., Paliga K., Durrwang U., Czech C. Evin G., Masters C. L., and Beyreuther K. (1997) Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β-amyloid precursor protein. Nat. Med. 3, 328-332.
226. Wertkin A. M., Turner R. S., Pleasure S. J., Golde T. E., Younkin S. G., Trojanowski J. Q., and Lee V. M.-Y. (1993) Human neurons derived from teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptide. Proc. Natl. Acad. Sci. USA 90, 9513-9517.
227. Wickelgren I. (1997) Estrogen stakes claim to cognition. Science 276, 675-678.
228. Wild-Bode C., Yamazaki T., Capell A., Leimer U., Steiner H., Ihara Y., and Haass C. (1997) Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42. J. Biol. Chem. 272, 16085-16088.
229. Wolf B. A., Wertkin A. M., Jolly Y. C., Yasuda R. P., Wolfe B. B., Konrad R. J., Manning D., Ravi S., Williamson J. R., and Lee V. M.-Y. (1995) Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid β-protein production in human neuronal NT2N cells. J. Biol. Chem. 270, 4916-4922.
230. Wolozin B., Hirashima N., Luo Y., Li Y., Alkon D., Etcheberrigaray R., and Sunderland T. (1995) Transforming growth factor β induces Aβ-responsive calcium currents in neurons. Neuroreport 6, 1301-1305.
231. Wolozin B. L., Jasaric-Keys J., Canter R., Li Y., Vanderputten D., and Sunderland T. (1996) Differential regulation of APP secretion by apolipoprotein E3 and E4. Ann. NY Acad. Sci. 777, 322-326.
232. Xia W., Zhang J., Perez R., Koo E. H., and Selkoe D. J. (1997) Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 94, 8208-8213.
233. Xu H., Greengard P., and Gandy S. (1995) Regulated formation of Golgi secretory vesicles containing Alzheimer β-amyloid precursor protein. J. Biol. Chem. 270, 23243-23245.
234. Xu H., Sweeney D., Greengard P., and Gandy S. (1996) Metabolism of Alzheimer β-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system. Proc. Natl. Acad. Sci. USA 93, 4081-4084.
235. Xu H., Gouras G. K., Greenfield J. P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J. N., Seeger M., Relkin N. R., Liao F., Checler F., Buxbaum J. D., Chait B. T., Thinakaran G., Sisodia S. S., Wang R., Greengard P., and Gandy S. (1998) Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat. Med. 4, 447-451.
236. Yan S. D., Yan S. F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M. A., Perry G., Godman G. C., Nawroth P., Zweirer J. L., and Stern D. (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat. Med. 1, 693-699.
237. Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
238. Yeagle P. L. (1991) Modulation of membrane function by cholesterol. Biochimie 73, 1303-1310.
239. Zhang C., Lambert M. P., Bunch C., Barber K., Wade W. S., Krafft G. A., and Klein W. L. (1994) Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's Aβ peptide. J. Biol. Chem. 269, 25247-25250.
240. Zheng H., Jiang M., Trumbauer M. E., Sirinathsinghji D. J. S., Hopkins R., Smith D. W., Heavens R. P., Dawson G. R., Boyce S., Conner M. W., Stevens K. A., Slunt H. H., Sisodia S. S., Chen H. Y., and Van der Ploeg L. H. T. (1995) β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525-531.